The use of preparations of immunoglobulins for prevention of development of gestosis and fetal loss syndrome

This paper assesses the preventive effect of administration of human immunoglobulin (pentaglobin) during the early stages of pregnancy in the presence of factors of risk of development of a systemic inflammatory response, such as viral infection, acute sinusitis, or bronchitis during the waves I and II of cytotrophoblast invasion; innate and acquired trombophilia; and autoimmune diseases. The proposed therapy contributes to localization of the inflammatory process, and reduction of the risk of development of gestosis and perinatal losses